Sid Mukher­jee, Lew Cant­ley be­hind new can­cer biotech with food+drug com­bo treat­ment am­bi­tions 

Famed on­col­o­gist Sid Mukher­jee and re­peat biotech co-founder Lew Cant­ley have teamed up to form Faeth Ther­a­peu­tics, a start­up aim­ing to treat can­cer the way oth­er con­di­tions are ad­dressed: pair­ing nu­tri­tion with ther­a­peu­tics.

The goal is to trans­form can­cer treat­ment with nu­tri­tion and make it the fourth “pil­lar” in the on­col­o­gy reg­i­men, which to date has cen­tered on ra­dio­ther­a­py, surgery and drugs, Faeth CEO Anand Parikh told End­points News. Oth­er con­di­tions have al­ready been ad­dressed with a side of nu­tri­ents or di­et, he said, point­ing to di­a­betes, ir­ri­ta­ble bow­el syn­drome and oth­er dis­eases.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER